Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Three Non-NNRTI-Sparing Antiretroviral Regimens
Clinical Trial Protocol ID
05020302

Clinical Trial Investigator Name
Beverly Sha, MD

Clinical Trial Title

A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers.

(The ARDENT Study: Atazanavir, Raltegravir, or Darunavir with Emtricitabine/Tenofovir for Naïve Treatment)



Clinical Trial Protocol Description

The purpose of this study is to compare the effectiveness and tolerability of three combination FDA-approved HIV medication regimens using Truvada (emtricitabine/tenofovir disoproxil fumarate) as a base along with:

  • Group A=Reyataz (atazanavir) and Norvir (ritonavir)
  • Group B=Isentress (raltegravir)
  • Group C=Prezista (darunavir) and Norvir (ritonavir)

Medications are open label. 

All medications will be provided except Norvir; but the co-pay for Norvir will be reimbursed with receipt.

You will be in this study between 96 weeks and 192 weeks depending on when you join.

About 1,800 people will take part in this study. We anticipate enrolling about 40 subjects for this study at Rush.



Clinical Trial Eligibility Criteria

In order to participate you must:

  • Be HIV positive
  • Have never taken HIV medication (exceptions are for pregnancy and post exposure prophylaxis)
  • Have an HIV viral load greater than or equal to 1,000 copies/ml within 90 days
  • Have HIV genotype test results
  • Be able to get Norvir with a prescription

You will be not be able to be in the study if you:

  • Have HIV mutations to the study drugs
  • Are pregnant or breast feeding
  • Used entecavir for hepatitis B treatment for over eight weeks while HIV positive
  • Have decompensated cirrhosis of the liver




Contact Name Veronica Navarro, RN
Contact Phone (312) 942-7761
Contact E-mail aidsclinic@rush.edu
Promotional Information

Clinical Trials Home
Infectious Disease Trials
Three Non-NNRTI-Sparing Antiretroviral Regimens

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois